.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Novartis
QuintilesIMS
Cerilliant
Johnson and Johnson
Federal Trade Commission
Colorcon
Moodys
Baxter
AstraZeneca

Generated: September 19, 2017

DrugPatentWatch Database Preview

HYDERGINE Drug Profile

« Back to Dashboard

Which patents cover Hydergine, and what generic Hydergine alternatives are available?

Hydergine is a drug marketed by Novartis and is included in four NDAs.

The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.

Summary for Tradename: HYDERGINE

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list7
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDERGINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
HYDERGINE
ergoloid mesylates
SOLUTION;ORAL018418-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
HYDERGINE
ergoloid mesylates
TABLET;ORAL017993-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
HYDERGINE
ergoloid mesylates
TABLET;SUBLINGUAL009087-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
HYDERGINE
ergoloid mesylates
TABLET;SUBLINGUAL009087-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
HYDERGINE LC
ergoloid mesylates
CAPSULE;ORAL018706-001Jan 18, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
HYDERGINE
ergoloid mesylates
TABLET;ORAL017993-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HYDERGINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
HYDERGINE
ergoloid mesylates
SOLUTION;ORAL018418-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chubb
Medtronic
Daiichi Sankyo
Fish and Richardson
Argus Health
Fuji
Chinese Patent Office
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot